STOCK-BASED COMPENSATION

Stock Options

There were no grants made during the three months ended September 30, 2017 and 2016.

Changes in our stock options for the three months ended September 30, 2017 were as follows:



	Options		Weighted Average Exercise Price		Weighted Average Remaining Life (years)	Aggregate Intrinsic value (in thousands)
Options outstanding, June 30, 2017	1,726,791		$	34.08
Granted	—		—
Exercised	(1,628	)	26.99
Lapsed or forfeited	(60,849	)	39.40
Options outstanding, September 30, 2017	1,664,314		$	33.89	4.5	$	12,406
Options vested and expected to vest, September 30, 2017	1,654,835		$	33.92	4.5	$	12,291
Options exercisable, September 30, 2017	1,383,912		$	35.47	3.8	$	8,380

During the three months ended September 30, 2017 and 2016, compensation expense related to stock options was $0.2 million and $0.5 million, respectively. As of September 30, 2017, the total unrecognized compensation cost related to options outstanding was $0.7 million and is expected to be recognized over a weighted average period of 1.0 year.

Fair value of options vested during the three months ended September 30, 2017 and 2016 was $1.6 million and $2.6 million, respectively.

No tax benefits were realized resulting from stock-based compensation deductions for the three months ended September 30, 2017 and 2016 due to the valuation allowance on U.S. deferred tax assets.

The amount of cash received from the exercise of capital stock options during the three months ended September 30, 2017 and 2016 was immaterial. No related tax benefit was realized for the three months ended September 30, 2017 and 2016 due to the valuation allowance on U.S. deferred tax assets. The total intrinsic value of options exercised during the three months ended September 30, 2017 and 2016 was immaterial.

Under the provisions of the Kennametal Inc. Stock and Incentive Plan of 2010 as amended and restated on October 22, 2013 and as further amended January 27, 2015, and the Kennametal Inc. 2016 Stock and Incentive Plan, plan participants may deliver stock, owned by the holder for at least six months, in payment of the option price and receive credit for the fair market value of the shares on the date of delivery. The fair market value of shares delivered during both the three months ended September 30, 2017 and 2016 was immaterial.

Restricted Stock Units – Time Vesting and Performance Vesting

Performance vesting restricted stock units are earned pro rata each year if certain performance goals are met over a three-year period and are also subject to a service condition that requires the individual to be employed by the Company at the vesting date after the three-year performance period, with the exception of retirement eligible grantees, who upon retirement are entitled to vest in any units that have been earned, including a prorated portion in the partially completed fiscal year in which the retirement occurs. Time vesting stock units are valued at the market value of the stock on the grant date. Performance vesting stock units with a market condition are valued using a Monte Carlo model.

Changes in our time vesting and performance vesting restricted stock units for the three months ended September 30, 2017 were as follows:



	Performance Vesting Stock Units		Performance Vesting Weighted Average Fair Value		Time Vesting Stock Units		Time Vesting Weighted Average Fair Value
Unvested, June 30, 2017	280,250		$	27.62	1,153,444		$	27.66
Granted	158,397		38.81		414,515		37.50
Vested	(10,031	)	42.83		(371,610	)	30.81
Performance metric adjustments, net	16,766		25.84		—		—
Forfeited	—		—		(10,311	)	32.50
Unvested, September 30, 2017	445,382		$	31.19	1,186,038		$	30.06

During the three months ended September 30, 2017 and 2016, compensation expense related to time vesting and performance vesting restricted stock units was $6.0 million and $8.3 million, respectively. As of September 30, 2017, the total unrecognized compensation cost related to unvested time vesting and performance vesting restricted stock units was $27.5 million and is expected to be recognized over a weighted average period of 2.3 years.